Patient isolator systems in cancer chemotherapy. The use of high-dose "nonabsorable" antibiotics in the reduction of bowel flora.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001414:Bacitracin / Q000627:therapeutic use; D001681:Biological Assay; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D004064:Digestive System / Q000382:microbiology; D004358:Drug Therapy; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects; D009355:Neomycin / Q000627:therapeutic use / Q000652:urine; D009369:Neoplasms / Q000188:drug therapy*; D009761:Nystatin / Q000627:therapeutic use; D010357:Patient Isolators / Q000706:statistics & numerical data*; D011113:Polymyxins / Q000627:therapeutic use; D011507:Proteinuria; D013242:Sterilization; D013432:Sulfathiazoles / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D011113:Polymyxins; D013432:Sulfathiazoles; D009761:Nystatin; D001414:Bacitracin; D007612:Kanamycin; D003404:Creatinine; D009355:Neomycin